Relevant bibliographies by topics / Vaccine effectiveness

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Vaccine effectiveness'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Vaccine effectiveness.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Vaccine effectiveness"

1

Pálinkás, Anita, and János Sándor. "Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study." Vaccines 10, no. 7 (2022): 1009. http://dx.doi.org/10.3390/vaccines10071009.

Full text
Abstract:
Our investigation aimed to describe the all-cause mortality rates by COVID-19 vaccination groups in Hungary for an epidemic period (1 April 2021–20 June 2021) and a nonepidemic period (21 June 2021–15 August 2021), and to determine the vaccines’ effectiveness in preventing all-cause mortality utilizing nonepidemic effectiveness measures to adjust for the healthy vaccinee effect (HVE). Sociodemographic status, comorbidity, primary care structural characteristics, and HVE-adjusted survival difference between fully vaccinated and unvaccinated cohorts in the epidemic period had been computed by Co
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Yihan. "Development, effectiveness, and future directions of HPV vaccines." Theoretical and Natural Science 67, no. 1 (2024): 17–21. https://doi.org/10.54254/2753-8818/2024.18021.

Full text
Abstract:
Human papillomavirus (HPV) vaccines are vaccines used to prevent sexually transmitted diseases caused by HPV. HPV infection is the leading causation that causing the cervical cancer. Specifically, high-risk-type, for instance, HPV-16 and HPV-18, are also connected with some other cancers. This article summarizes the development mechanism, availability, clinical trials, and problems faced by HPV vaccines. Currently, there were three approved HPV vaccines, including bivalent vaccine, quadrivalent vaccine, and nine-valent vaccine, which can prevent different types of HPV infection. The widely uti
APA, Harvard, Vancouver, ISO, and other styles
3

Helena De Oliveira, Lucia, Barbara Jauregui, Ana Flavia Carvalho, and Norberto Giglio. "Impact and effectiveness of meningococcal vaccines: a review." Revista Panamericana de Salud Pública 41 (December 20, 2017): 1. http://dx.doi.org/10.26633/rpsp.2017.158.

Full text
Abstract:
Objectives.To summarize and critically evaluate the evidence on the impact and effectiveness of meningococcal vaccination programs around the world in order to inform decisionmaking in Latin America and the Caribbean.Methods.A review of the literature was conducted following several components of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed Central® was searched for papers published in any language from January 1999 – March 2017.Results.In all, 32 studies were included, most of which evaluated the meningococcal C conjugate vaccine. Fourteen studies
APA, Harvard, Vancouver, ISO, and other styles
4

Nouf, Khalid Binnujayfan Ayat Essam Shaban Mohammed Fayez Mohammed Alshehri Marwan Abdulmalik Altalhi Abdullah Mohammed Aljumah Ramzi Ali H. Arishi Fahad Ahmed Ali Alkanfari Njood Mohammed Siddiq Albangali Eidah Mohammed Al Ahmari Wed Ziyad Alnajjar Rawan Mohammad AlMuhanna Nourah Abdullah Alshahrani. "EFFECTIVENESS OF FLU SHOT VACCINE." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 06, no. 01 (2019): 1902–6. https://doi.org/10.5281/zenodo.2548755.

Full text
Abstract:
<strong><em>Introduction:</em></strong><em> Influenza is responsible for serious illness, especially in elderly. It has short term morbidity as well as long term morbidity and mortality during the acute infection, recovery could be long and sometimes incomplete. This could lead to persistent decrease in health and function, involving catastrophic disability, which has acute complications on the well-being and support needs of older adults and their caregivers. This means that prevention of infection and effective management when illness has occurred are of great importance.</em> <em>This sets
APA, Harvard, Vancouver, ISO, and other styles
5

Lau, Chin Shern, and Tar Choon Aw. "Considerations in Understanding Vaccine Effectiveness." Vaccines 11, no. 1 (2022): 20. http://dx.doi.org/10.3390/vaccines11010020.

Full text
Abstract:
Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the population. Disease prevalence significantly impacts absolute risk reduction and could skew expected efficacy when increased disease prevalence inflates the absolute risk reduction in the face of a constant relative risk reduction. These factors must be considered in the interpretation of vaccine eff
APA, Harvard, Vancouver, ISO, and other styles
6

Fly, Mary. "Vaccine Effectiveness." Brain & Life 17, no. 2 (2021): 8. http://dx.doi.org/10.1097/01.nnn.0000742788.44428.40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stöckli, Sabrina, Anna Katharina Spälti, Joseph Phillips, et al. "Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment." PLOS ONE 17, no. 5 (2022): e0266003. http://dx.doi.org/10.1371/journal.pone.0266003.

Full text
Abstract:
Why do people prefer one particular COVID-19 vaccine over another? We conducted a pre-registered conjoint experiment (n = 5,432) in France, Germany, and Sweden in which respondents rated the favorability of and chose between pairs of hypothetical COVID-19 vaccines. Differences in effectiveness and the prevalence of side-effects had the largest effects on vaccine preferences. Factors with smaller effects include country of origin (respondents are less favorable to vaccines of Chinese and Russian origin), and vaccine technology (respondents exhibited a small preference for hypothetical mRNA vacc
APA, Harvard, Vancouver, ISO, and other styles
8

Bansal, Devendra, Jazeel Abdulmajeed, Maha H. M. A. Al-Shamali, et al. "Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease." Vaccines 10, no. 7 (2022): 1036. http://dx.doi.org/10.3390/vaccines10071036.

Full text
Abstract:
Waning immunity following administration of mRNA-based COVID-19 vaccines remains a concern for many health systems. We undertook a study to determine if recent reports of waning for severe disease could have been attributed to design-related bias by conducting a study only among those detected with a first SARS-CoV-2 infection. We used a matched case-control study design with the study base being all individuals with first infection with SARS-CoV-2 reported in the State of Qatar between 1 January 2021 and 20 February 2022. Cases were those detected with first SARS-CoV-2 infection requiring int
APA, Harvard, Vancouver, ISO, and other styles
9

Rajaram, Sankarasubramanian, Constantina Boikos, Daniele K. Gelone, and Ashesh Gandhi. "Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing." Therapeutic Advances in Vaccines and Immunotherapy 8 (January 2020): 251513552090812. http://dx.doi.org/10.1177/2515135520908121.

Full text
Abstract:
Influenza continues to cause severe illness in millions and deaths in hundreds of thousands annually. Vaccines are used to prevent influenza outbreaks, however, the influenza virus mutates and annual vaccination is required for optimal protection. Vaccine effectiveness is also affected by other potential factors such as the human immune system, a mismatch with the chosen candidate virus, and egg adaptation associated with egg-based vaccine production. This article reviews the influenza vaccine development process and describes the implications of the changes to the cell-culture process and vac
APA, Harvard, Vancouver, ISO, and other styles
10

Diogo José Horst and Charles Adriano Duvoisin. "The doubtful effectiveness of the COVID-19 vaccine." GSC Biological and Pharmaceutical Sciences 15, no. 2 (2021): 151–57. http://dx.doi.org/10.30574/gscbps.2021.15.2.0132.

Full text
Abstract:
A COVID-19 pandemic has erupted around the world. World Health Organization (WHO) and allies are racing to create and deploy safe and effective vaccines as they work together to monitor the pandemic, advise on crucial measures, and distribute essential medical resources to those in need. Vaccines save millions of lives, by training the body's natural defenses, the immune system, to identify and combat the viruses and bacteria they are intended to combat. This review article presents the status of COVID-19 vaccines evaluated by the WHO Emergency Use Listing (EUL) assessment process and those li
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Vaccine effectiveness"

1

Channing, Liezl. "Cost-effectiveness analysis of MVA85 vaccine: a new TB vaccine candidate." Master's thesis, University of Cape Town, 2013. http://hdl.handle.net/11427/9448.

Full text
Abstract:
Includes bibliographical references.<br>Tuberculosis (TB) remains a major public health concern. The BCG vaccine is, currently, the only vaccine against TB and, although it provides some protection against disseminated forms of TB, its effectiveness in preventing primary infection and disease progression to pulmonary TB is highly varied. A number of potential new TB vaccine candidates have been identified and are, currently, undergoing clinical trials. One such candidate is MVA85A. This study aims to assess the potential cost-effectiveness of a new TB vaccine, the MVA85A vaccine. The study com
APA, Harvard, Vancouver, ISO, and other styles
2

McIntyre, Peter. "Measuring the public health impact of vaccines: disease burden, vaccine coverage, safety and effectiveness." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/26251.

Full text
Abstract:
This thesis has eight chapters describing inter-relationships between work in 66 papers published between 1999 and 2020 relevant to the over-arching topic of public health impact of vaccines: measurement of disease burden, vaccine coverage, safety and effectiveness Chapter 1 outlines the key data sources used: 1. routinely collected administrative data (disease notifications, ICD coded hospitalisations and mortality data) and 2. additional data sources the author had a key role in developing (National Serosurveillance. Paediatric Active Enhanced Surveillance (PAEDS). In chapter 4, developmen
APA, Harvard, Vancouver, ISO, and other styles
3

Leung, May-bo Mabel, and 梁美寶. "The cost effectiveness of varicella vaccination program : a systemic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206948.

Full text
Abstract:
Background Chickenpox is a common infectious disease among children. Ever since a live attenuated vaccine was developed in 1970s, different countries have adopted different vaccination program against chickenpox. Hong Kong recently has commenced a routine childhood varicella vaccination program. The objective of this study is to evaluate whether routine childhood varicella vaccination is cost effective and the implications to Hong Kong. Methodology Literature search was done on electronic databases: Medline and Embase for articles relevant to the topic. A total of 9 articles were retrieve
APA, Harvard, Vancouver, ISO, and other styles
4

Wadanambi, Arachchige Sanjay Harsha Jayasinghe. "Long-term impact and effectiveness of vaccines on invasive pneumococcal disease in Australian children." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20156.

Full text
Abstract:
Pneumococcal disease is a leading cause of morbidity and mortality in children globally. Pneumococcal conjugate vaccines (PCVs), available since early 2000, had proven efficacy to prevent invasive pneumococcal disease (IPD)-the sever form of pneumococcal infections. For Australian children PCV had been publicly funded through the national immunisation program, initially in 2001 for those with increased disease risk which included Aboriginal and Torres Strait Islander children and from 2005 for all children. The schedule of PCV used in Australia comprising three doses at age 2, 4 and 6 months (
APA, Harvard, Vancouver, ISO, and other styles
5

Wong, Kwan-ting, and 王筠婷. "The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/206978.

Full text
Abstract:
BACKGROUND: Despite the current recommendation by the Centre for Health Protection (CHP)of Hong Kong for adults aged 65 years or above to receive 23-valent pneumococcal polysaccharide vaccine (PPV23), pneumococcal disease(PD) has become the second leading causes of death in Hong Kong. A relatively new pneumococcal vaccine –13-valent pneumococcal conjugate vaccine (PCV13) was approved by the US Food and Drug Administration (FDA) in December 2011 and the European Medicines Agency (EMA) in July 2013 for the prevention of invasive disease caused by S. pneumoniae for older adults aged 50 years or a
APA, Harvard, Vancouver, ISO, and other styles
6

Donauer, Stephanie. "Determining the Post-Licensure Effectiveness of Pentavalent Rotavirus Vaccine using Observational Study Designs." University of Cincinnati / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368026785.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Skull, Susan. "Effectiveness of influenza and pneumococcal vaccination against hospitalisation for community-acquired pneumonia among persons >65 years /." Connect to thesis, 2007. http://repository.unimelb.edu.au/10187/1998.

Full text
Abstract:
Although there are well-documented benefits from influenza vaccine and 23-valent pneumococcal polysaccharide vaccine (23vPPV) against invasive pneumococcal disease and laboratory confirmed influenza, their effectiveness against pneumonia remains controversial for community-based persons aged >=65years. At the time of this research, within Australia, only the government of Victoria publicly funded these vaccines for elderly persons. With continued growth of the elderly population, the subsequent adoption of an Australia-wide program, and increasing uptake of similar programs in other countries,
APA, Harvard, Vancouver, ISO, and other styles
8

De, La Hoz Fernando. "Hepatitis B vaccination in the Columbian Amazon : effectiveness and factors influencing vaccine coverage." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2003. http://researchonline.lshtm.ac.uk/1544171/.

Full text
Abstract:
A vaccination coverage survey was carried out in the Colombian Amazon, a former high endemic area for hepatitis B, involving 3573 children less than II years old. It was carried out in Leticia, Puerto Narifio, and Araracuara, both urban and rural areas. Children were selected using a one stage cluster sampling, randomly selecting clusters in urban and rural areas where all children under 11 were surveyed. At the same time blood samples were taken from all children with known vaccination status (n=1603), and from their mother, when she was available (n=8l2). These samples were processed for hep
APA, Harvard, Vancouver, ISO, and other styles
9

Bennett, Aisleen May. "Rotavirus transmission in the context of reduced vaccine effectiveness in low income countries." Thesis, University of Liverpool, 2018. http://livrepository.liverpool.ac.uk/3019186/.

Full text
Abstract:
Introduction. Rotavirus vaccine has been introduced into over 80 countries with substantial impact on rotavirus disease. However vaccine effectiveness is reduced in low-income countries. Patterns of rotavirus transmission could explain some of the observed reduced vaccine effectiveness, and vaccine-mediated reductions in rotavirus transmission may increase overall vaccine impact. A detailed understanding of rotavirus transmission in low income countries (LIC) is required to inform policy decisions to improve vaccine performance, however such data are currently lacking. Methods. Mixture models
APA, Harvard, Vancouver, ISO, and other styles
10

Rondy, Marc. "Efficacité post autorisation de mise sur le marché de la vaccination antigrippale saisonnière contre l’hospitalisation avec une grippe confirmée virologiquement chez l’adulte en Europe." Thesis, Bordeaux, 2017. http://www.theses.fr/2017BORD0684/document.

Full text
Abstract:
Notre objectif était de mesurer chez les adultes en Europe l’efficacité des vaccins (EV) anti-grippaux saisonniers contre l’hospitalisation avec une grippe confirmée en laboratoire. Nous avons coordonné une étude cas-témoins multicentrique dans 29 hôpitaux de 12 pays entre 2011 et 2017. Nous avons fait une analyse des données groupées lors de chaque saison grippale. Entre 2011-12 et 2016-17, nous avons recruté 3436 cas de grippe et 5969 témoins. L’EV tous virus confondus était de 26% ; elle était de 40% chez les 18-64 ans, 25% chez les 65-79 ans et 23% chez les 80 ans et plus. Par saison, l’EV
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Vaccine effectiveness"

1

Shalala, Donna E. Medicare influenza vaccine demonstration: Report to Congress. Dept. of Health and Human Services], 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

R, Berndt Ernst, and National Bureau of Economic Research., eds. Advanced purchase commitments for a malaria vaccine: Estimating costs and effectiveness. National Bureau of Economic Research, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Berndt Ernst, and National Bureau of Economic Research., eds. Advanced purchase commitments for a malaria vaccine: Estimating costs and effectiveness. National Bureau of Economic Research, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hersack, Richard A. The anthrax vaccine debate: A medical review for commanders. USAF Counterproliferation Center, Air War College, Air University, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sullivan, Louis Wade. Cost-effectiveness demonstration of Medicare coverage of influenza vaccine: Report to Congress. Dept. of Health and Human Services], 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Taehak, Sŏul Taehakkyo Ŭikwa, ред. Inpʻŭlluenja paeksin (soa) yuyongsŏng pʻyŏngka yŏnʼgu: Yŏnʼgu kyŏlgwa pogosŏ = Evaluation of efficacy of influenza vaccine in children. Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chan, Kwai-Cheung. Medical readiness: Issues concerning the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. The Office, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chan, Kwai-Cheung. Medical readiness: Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. The Office, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chan, Kwai-Cheung. Medical readiness: Safety and efficacy of the anthrax vaccine : statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division, before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives. The Office, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Weiss, Robin. Surrogate endpoints in evaluating the effectiveness of drugs against HIV infection and AIDs: September 11-12, 1989, conference summary. Edited by United States. Army Medical Research and Development Command, National Research Council (U.S.), and Roundtable for the Development of Drugs and Vaccines against AIDS (Institute of Medicine). National Academy Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Vaccine effectiveness"

1

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Vaccine effectiveness." In Vaccination Programmes. Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nauta, Jozef. "Vaccine Effectiveness Studies." In Springer Series in Pharmaceutical Statistics. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-37693-2_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Estimating vaccine effectiveness." In Vaccination Programmes. Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Estimating vaccine effectiveness." In Vaccination Programmes. Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Estimating vaccine effectiveness." In Vaccination Programmes. Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kerns, Thomas A. "Criteria of Effectiveness." In Ethical Issues in HIV Vaccine Trials. Palgrave Macmillan UK, 1997. http://dx.doi.org/10.1057/9780230380011_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hahné, Susan, Kaatje Bollaerts, and Paddy Farrington. "Waning vaccine effectiveness and modes of vaccine action." In Vaccination Programmes. Routledge, 2021. http://dx.doi.org/10.4324/9781315166414-20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

de Carvalho Clímaco, Marianna, Lucas Kraemer, and Ricardo Toshio Fujiwara. "Vaccine Development for Human Leishmaniasis." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_14.

Full text
Abstract:
AbstractThe development of vaccines for human leishmaniasis is one of the most important approaches for effectively controlling and/or eradicating the several forms of the disease. Based on the knowledge obtained from the practice of leishmanization and its protective immune response, several strategies have been used to develop vaccines against Leishmania species, such as the use of whole killed and attenuated parasites, recombinant proteins, and DNA vaccines. An ideal vaccine should be safe, effective, and immunogenic. Although several candidates have achieved safety and some level of effect
APA, Harvard, Vancouver, ISO, and other styles
9

Nauta, Jozef. "Meta-Analysis of Vaccine Effectiveness Studies." In Springer Series in Pharmaceutical Statistics. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-37693-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mueller, Siguna. "The Challenge of Evaluating Vaccine Safety and Effectiveness." In Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-18903-6_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Vaccine effectiveness"

1

Zughaier, Susu. "High Vaccine Coverage is Crucial for Preventing the Spread of Infectious Diseases During Mass Gathering." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0138.

Full text
Abstract:
Background: Vaccines are the most cost-effective intervention in public health as they prevent the spread of highly contagious infectious diseases. Because of vaccine implementation and high coverage, Measles was eradicated in 2000, however the recent reappearance of measles in the United States, Europe and globally is alarming. The resurgence of Measles, Diphtheria and Mumps is due to a reduction in vaccine coverage and herd immunity. Vaccine hesitant parents, antivaxxers, and fake news on vaccines are driving the surge in those infectious diseases. The World Health Organization issued the Gl
APA, Harvard, Vancouver, ISO, and other styles
2

Katz, Mark. "Understanding COVID-19 vaccine effectiveness in preventing severe disease." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24012k.

Full text
Abstract:
Understanding COVID-19 vaccine effectiveness (VE) in preventing severe disease is critical to inform vaccine policy. In this talk I will describe the results of a study that used the test-negative design to estimate VE against SARS-CoV-2-confirmed hospitalisation in adults ≥ 18 years in the Eastern part of the WHO European region. We included patients hospitalised for severe acute respiratory infection (SARI) at sentinel surveillance sites in six countries and areas, including in Serbia. We collected demographic information, COVID-19 vaccination history, and tested respiratory samples for SARS
APA, Harvard, Vancouver, ISO, and other styles
3

Tarabrin, R. E., and E. S. Pyatigorec. "BIOETHICAL ISSUES OF VACCINOMICS." In I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-130.

Full text
Abstract:
Vaccinomics, as one of the areas of personalized medicine, can increase the effectiveness of&#x0D; vaccines, including in epidemics. Nevertheless, it is accompanied by a cluster of bioethical issues.&#x0D; The article explores possible bioethical difficulties associated with the development of personalized&#x0D; vaccines: the matching of the research subject and the person receiving the vaccine; the problem of&#x0D; confidential genetic data; equitable distribution of medical resources.
APA, Harvard, Vancouver, ISO, and other styles
4

Araújo, Simone Rodrigues da Silva, Ludmilla Pinto Guiotti Cintra Abreu, Marilene dos Santos Pereira, et al. "Safety and effectiveness analysis of the HPV vaccine: Comprehensive review." In III Seven International Medical and Nursing Congress. Seven Congress, 2024. http://dx.doi.org/10.56238/iiicongressmedicalnursing-005.

Full text
Abstract:
Cervical cancer has become a serious public health problem in Brazil, as it is a slow-developing disease with a high impact on prevalence and mortality rates, especially in women with lower social and economic status who are in the productive period of their lives. It can be triggered by persistent infection with oncogenic subtypes of the Human Papillomavirus, mainly 16 and 18. The objective of this narrative review was to analyze and review the main articles available on the safety and effectiveness of the HPV vaccine. This is a comprehensive review of the literature, with narrative synthesis
APA, Harvard, Vancouver, ISO, and other styles
5

Capão, Artur, Braulia Caetano, Paola Resende, et al. "Effectiveness of 2018 trivalent influenza vaccine on healthcare professionals." In IV International Symposium on Immunobiologicals & VII Seminário Anual Científico e Tecnológico. Instituto de Tecnologia em Imunobiológicos, 2019. http://dx.doi.org/10.35259/isi.sact.2019_32545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Adami, Giovanni, Angelo Fassio, Giovanni Orsolini, Alessandro Giollo, Davide Gatti, and Maurizio Rossini. "OP0230 EFFECTIVENESS OF INFLUENZA VACCINE IN TNF INHIBITORS TREATED PATIENTS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Araújo, Simone Rodrigues da Silva, Ludmilla Pinto Guiotti Cintra Abreu, Ronaldo Gonçalves Abreu, et al. "Yellow fever in Brazil: Reflections on vaccine safety and effectiveness." In IV Seven International Congress of Health. Seven Congress, 2024. http://dx.doi.org/10.56238/homeivsevenhealth-004.

Full text
Abstract:
Yellow fever is an arbovirus caused by a virus of the Flavivirus genus, endemic in tropical regions of Africa and South America. Transmission occurs mainly through the bite of infected mosquitoes, especially of the Haemagogus or Sabethes genera, which contract the virus from monkeys. There is also inter-human transmission via the Aedes aegypti mosquito. The disease is severe and hemorrhagic, with nonspecific initial symptoms, followed by periods of remission and toxemia, characterized by hemorrhagic manifestations and acute liver failure. Approximately 50% of cases are non-specific, 20% have f
APA, Harvard, Vancouver, ISO, and other styles
8

Vasileiou, Eleftheria, Colin Simpson, Aziz Sheikh, and Chris Butler. "Seasonal influenza vaccine effectiveness in people with asthma: A systematic review." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa4205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kurniawati, Hidayatul, Niko Tri Fasluky Oktavio, and Seshy Tinartayu. "Effectiveness of paracetamol administration on pain in Covid-19 vaccine booster." In 12TH INTERNATIONAL SEMINAR ON NEW PARADIGM AND INNOVATION ON NATURAL SCIENCES AND ITS APPLICATIONS (12TH ISNPINSA): Contribution of Science and Technology in the Changing World. AIP Publishing, 2024. http://dx.doi.org/10.1063/5.0218058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Xiao, Yichen, Han-Ching Ou, Haipeng Chen, Van Thieu Nguyen, and Long Tran-Thanh. "Sequential Vaccine Allocation with Delayed Feedback." In Thirty-First International Joint Conference on Artificial Intelligence {IJCAI-22}. International Joint Conferences on Artificial Intelligence Organization, 2022. http://dx.doi.org/10.24963/ijcai.2022/722.

Full text
Abstract:
In this work we consider the problem of how to best allocate a limited supply of vaccines in the aftermath of an infectious disease outbreak by viewing the problem as a sequential game between a learner and an environment (specifically, a bandit problem). The difficulty of this problem lies in the fact that the payoff of vaccination cannot be directly observed, making it difficult to compare the relative effectiveness of vaccination on different population groups. Currently used vaccination policies make recommendations based on mathematical modelling and ethical considerations. These policies
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Vaccine effectiveness"

1

Anderson, Michael, Carlos Dobkin, Devon Gorry, and Hung-Fu Tseng. Real-world Effectiveness of the Influenza Vaccine in Young Children. National Bureau of Economic Research, 2025. https://doi.org/10.3386/w33856.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Berndt, Ernst, Rachel Glennerster, Michael Kremer, et al. Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness. National Bureau of Economic Research, 2005. http://dx.doi.org/10.3386/w11288.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alsan, Marcella, and Sarah Eichmeyer. Experimental Evidence on the Effectiveness of Non-Experts for Improving Vaccine Demand. National Bureau of Economic Research, 2021. http://dx.doi.org/10.3386/w28593.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Russell, Kevin L., Margaret A. Ryan, Anthony Hawksworth, Nikki E. Freed, Marina Irvine, and Luke T. Daum. Effectiveness of the 2003/2004 Influenza Vaccine Among U.S. Military Basic Trainees: A Year of Suboptimal Match Between Vaccine and Circulating Strain. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada455912.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Díaz, Lina M., Déborah Martínez Villarreal, Karina Olenka Stella Marquez Guerra, and Carlos Scartascini. Combating Vaccine Hesitancy: The Case of HPV Vaccination. Inter-American Development Bank, 2025. https://doi.org/10.18235/0013410.

Full text
Abstract:
Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains one of the leading causes of cancer-related deaths among women in developing countries. Although HPV vaccines are widely available in these regions, vaccine uptake remains persistently low. To address behavioral barriers contributing to this low demand, we evaluated the effectiveness of a behaviorally informed SMS campaign targeting parents in Cali, Colombia. Our study included 15,231 parents, who were randomized into six groups: control, placebo, and four behaviorally informed treatment groups, formi
APA, Harvard, Vancouver, ISO, and other styles
6

Tinessia, Adeline, Catherine King, Madeleine Randell, and Julie Leask. The effectiveness of strategies to address vaccine hesitancy in Aboriginal and Torres Strait Islander peoples. The Sax Institute, 2022. http://dx.doi.org/10.57022/fobi4392.

Full text
Abstract:
This Evidence Snapshot provides a rapid review of evidence on strategies to address COVID-19 vaccine hesitancy in Aboriginal and Torres Strait Islander peoples. The authors examined strategies to address vaccine hesitancy among Indigenous peoples in well-resourced settings worldwide, focusing on COVID-19 vaccination and the program roll-out. The review included peer-reviewed and grey literature published up to December 2021. Most studies were descriptive qualitative or quantitative with few intervention or evaluation reports to date. However, the review specifically lists author-recommended in
APA, Harvard, Vancouver, ISO, and other styles
7

Paris, Chloe, Julie Spencer, Lauren Castro, and Sara Del Valle. Exploring Impacts to COVID-19 Herd Immunity Thresholds Under Demographic Heterogeneity that Lowers Vaccine Effectiveness. Office of Scientific and Technical Information (OSTI), 2022. http://dx.doi.org/10.2172/1874147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Xu, Junjie, Jiaye Liu, Xinquan Lan, Moxin Song, Liangyuan Zhang, and Jiaqi Zhang. Efficacy of the third dose of COVID-19 vaccine: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0114.

Full text
Abstract:
Review question / Objective: To investigate the immune response and related clinical outcomes of healthy adults who received coronavirus vaccine booster compared with those who did not receive the vaccine booster. Condition being studied: The COVID-19 pandemic, which has spread since 2019, has created a huge disease and economic burden on the world. A large number of clinical trials have verified the effectiveness of COVID-19 vaccine. Previous studies have found that the serum conversion rate and antibody level of those vaccinated after the first two doses of COVID-19 vaccine continue to decre
APA, Harvard, Vancouver, ISO, and other styles
9

A, Bengolea, Chamorro F, Catalano HN, and Izcovich A. Assessing the safety and effectiveness of the bivalent vaccine against respiratory syncytial virus in pregnant women: a systematic review. Epistemonikos Interactive Evidence Synthesis, 2024. http://dx.doi.org/10.30846/ies.ac54af0724.

Full text
Abstract:
Objective The aim of this systematic review is to conduct a comprehensive assessment of the efficacy and safety of the bivalent vaccine against the respiratory syncytial virus (RSV) compared to the placebo or the absence of vaccination in pregnant women to inform a clinical recommendation at the internal medicine department of Hospital Alemán of Buenos Aires. Methods In order to identify randomized clinical trials that evaluate our question of interest, we carry out thorough searches in Epistemonikos and Pubmed, from the date of creation of each source until January of the year 2024. Additiona
APA, Harvard, Vancouver, ISO, and other styles
10

A, Bengolea, Chamorro F, Catalano HN, and Izcovich A. Assessing the safety and effectiveness of the bivalent vaccine against respiratory syncytial virus in pregnant women: a systematic review. Epistemonikos Interactive Evidence Synthesis, 2024. http://dx.doi.org/10.30846/ies.ac54af0724.v1.

Full text
Abstract:
Objective The aim of this systematic review is to conduct a comprehensive assessment of the efficacy and safety of the bivalent vaccine against the respiratory syncytial virus (RSV) compared to the placebo or the absence of vaccination in pregnant women to inform a clinical recommendation at the internal medicine department of Hospital Alemán of Buenos Aires. Methods In order to identify randomized clinical trials that evaluate our question of interest, we carry out thorough searches in Epistemonikos and Pubmed, from the date of creation of each source until January of the year 2024. Additiona
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Vaccine effectiveness' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography